Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer

Based on single agent activities and the additive or synergistic effects of three individual drugs in gastric cancer, we performed a phase II study of a new regimen combining epirubicin, docetaxel and cisplatin (EDP) for unresectable gastric cancer. The patients with histologically confirmed metasta...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lee, S-H, Kang, W K, Park, J, Kim, H Y, Kim, J H, Lee, S I, Park, J O, Kim, K, Jung, C W, Park, Y S, Im, Y-H, Lee, M H, Park, K
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2004
Gaiak:
Clinical
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2364756/
https://ncbi.nlm.nih.gov/pubmed/15188010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601891
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak